Skip to content
Institutional Investor seed Series A early to mid-stage Est. 1981

Advent Life Sciences

Early and mid-stage life science focused VC firm investing in the US and Europe

📍 London, United Kingdom

About This Fund

Advent Life Sciences is an early and mid-stage venture capital firm which makes investments in the US, Europe. The firm invests in Life Sciences companies operating in sectors such as Therapeutics, Diagnostics and Biopharma. Top investments include Acutus Medical, CardioKine, PowderMed, Versartis, etc.

Investment Focus

Sectors
new drug discovery across all modalities med tech enabling technologies vaccines diagnostics
Stages
seed Series A early to mid-stage
Check Size $10M-$50M
Geography
USA UK Europe

What They Look For

first-in-class or best-in-class approach to unmet medical needs; breakthrough science turned into approved medicines or medical products; UK, Europe, USA geography

Preparing to pitch Advent Life Sciences?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →